Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Colorectal Disease"
DOI: 10.1007/s00384-020-03509-x
Abstract: To determine the efficacy and safety data of aflibercept + FOLFIRI in wt RAS mCRC patients after progression to standard chemotherapy + anti-EGFR treatment. Retrospective, observational study in real life conducted in wt RAS mCRC patients treated with FOLFIRI-aflibercept… read more here.
Keywords: first line; treatment; anti egfr; ras mcrc ... See more keywords